NICE has withdrawn technical patient safety solutions for ventilator-associated pneumonia in adults, because the recommended action in section 1.2 on administering oral chlorhexidine is no longer supported by the evidence, and risks causing harm. 

The recommended action in section 1.1 of the guidance will be encompassed in the scope of the future NICE guideline on prevention of morbidity and mortality from healthcare-associated infections, if considered appropriate when NICE is preparing the scope for that guideline.